CH
GLMD icon

CVI Holdings’s Galmed Pharmaceuticals GLMD Stock Holding History

CVI Holdings’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$13.5K Sell
3,937
-2,285
-37% -$10K 0.01% 83
2024
Q1 		$24.5K Sell
6,222
-16,215
-72% -$73.1K 0.02% 59
2023
Q4 		$123K Buy
22,437
+1,655
+8% +$7.88K 0.25% 36
2023
Q3 		$155K Buy
+20,782
New +$276K 0.31% 35
2018
Q3 		– Sell
-83
Closed -$177K – 46
2018
Q2 		$177K Buy
+83
New +$120K 0.22% 30

Other funds holding GLMD

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return

CVI Holdings's GLMD Position: Q2 2024 in Review

CVI Holdings reduced its Galmed Pharmaceuticals (GLMD) stake by 37% in Q2 2024, selling an estimated $10K and leaving 3,937 shares worth $13.5K. The position accounts for 0.01% of the portfolio, ranked #83.

CVI Holdings first reported a position in GLMD in Q2 2018 and has held it in 5 quarters since. The position peaked at $177K in Q2 2018. 12 funds tracked by Wall St. Rank hold GLMD as of Q2 2024.

  • CVI Holdings held 3,937 shares of Galmed Pharmaceuticals worth $13.5K as of Q2 2024.
  • CVI Holdings sold 2,285 Galmed Pharmaceuticals shares in Q2 2024, an estimated $10K.
  • Galmed Pharmaceuticals made up 0.01% of CVI Holdings's portfolio in Q2 2024, its #83 holding.
  • CVI Holdings first reported a position in Galmed Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
  • CVI Holdings's Galmed Pharmaceuticals position peaked at $177K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.